Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000022530
JPRN-UMIN000022530Completed未知

Multi-institutional retrospective analysis of high-dose-rate brachytherapy combined with external beam radiotherapy for prostate cancer - Multi-institutional study of HDR combined with EBRT for prostate cancer

kitasato univerisity0 sites3,000 target enrollmentStarted: May 30, 2016Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
3,000
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

High-dose-rate brachytherapy combined with external beam radiotherapy was an effective and safe treatment for localized prostate cancer. Combination of long-term ADT was suggested to be necessary, even for HDR brachytherapy, and was useful in suppressing late toxicities. Meanwhile, pelvic irradiation was suggested to have an adverse effect on OS of our study population.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
ot applicable to ot applicable (—)
Sex
Male

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Investigators

Sponsor
kitasato univerisity

Similar Trials

Completed
Phase 2
A Study of Patients Receiving High-Dose Rate BrachytherapyEndometrial CancerBiliary CancerCervical CancerProstate CancerEsophageal Cancer
NCT00924027National Cancer Institute (NCI)42
Active, not recruiting
Phase 2
Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate CancerStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8Stage IIB Prostate Cancer AJCC v8Stage IIC Prostate Cancer AJCC v8
NCT04253483Rutgers, The State University of New Jersey14
Unknown
Phase 2
A Phase II Trial of High Dose-Rate Brachytherapy as Monotherapy in Low and Intermediate Risk Prostate CancerCarcinoma of the Prostate
NCT01890096Sunnybrook Health Sciences Centre174
Recruiting
Not Applicable
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate AdenocarcinomaProstate AdenocarcinomaStage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIC Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8Stage IIIA Prostate Cancer AJCC v8Stage IIIB Prostate Cancer AJCC v8Stage IIIC Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8
NCT04945642Jonsson Comprehensive Cancer Center52
Completed
Phase 2
Radiation Therapy in Treating Patients With Stage II or Stage III Prostate CancerProstate Cancer
NCT00091390Radiation Therapy Oncology Group129